Covalon Technologies Ltd. (COV.V)
| Previous close | 1.2000 |
| Open | 1.2000 |
| Bid | 1.1000 x 0 |
| Ask | 1.2300 x 0 |
| Day's range | 1.0800 - 1.2000 |
| 52-week range | 0.9600 - 2.1400 |
| Volume | |
| Avg. volume | 4,246 |
| Market cap | 26.89M |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1900 |
| Earnings date | 23 May 2024 - 27 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireCovalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders
MISSISSAUGA, Ontario, March 07, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders ("AGM") held March 6, 2024.
Business WireCovalon Announces First Quarter Fiscal 2024 Results
MISSISSAUGA, Ontario, February 28, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.
Business WireCovalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024
MISSISSAUGA, Ontario, February 28, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 6, 2024 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s recently appointed CEO, Brent Ashton, with
